297 related articles for article (PubMed ID: 20713408)
1. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
[TBL] [Abstract][Full Text] [Related]
2. Heralding cerebellar mutism: evidence for pre-surgical language impairment as primary risk factor in posterior fossa surgery.
Di Rocco C; Chieffo D; Frassanito P; Caldarelli M; Massimi L; Tamburrini G
Cerebellum; 2011 Sep; 10(3):551-62. PubMed ID: 21476131
[TBL] [Abstract][Full Text] [Related]
3. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
[TBL] [Abstract][Full Text] [Related]
5. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
7. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
[TBL] [Abstract][Full Text] [Related]
8. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
[TBL] [Abstract][Full Text] [Related]
9. Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance.
Suresh H; Morgan BR; Mithani K; Warsi NM; Yan H; Germann J; Boutet A; Loh A; Gouveia FV; Young J; Quon J; Morgado F; Lerch J; Lozano AM; Al-Fatly B; Kühn AA; Laughlin S; Dewan MC; Mabbott D; Gorodetsky C; Bartels U; Huang A; Tabori U; Rutka JT; Drake JM; Kulkarni AV; Dirks P; Taylor MD; Ramaswamy V; Ibrahim GM
Neuro Oncol; 2024 May; 26(5):950-964. PubMed ID: 38079480
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological Profile in Children with Posterior Fossa Tumors with or Without Postoperative Cerebellar Mutism Syndrome (CMS).
Cámara S; Fournier MC; Cordero P; Melero J; Robles F; Esteso B; Vara MT; Rodríguez S; Lassaletta Á; Budke M
Cerebellum; 2020 Feb; 19(1):78-88. PubMed ID: 31832994
[TBL] [Abstract][Full Text] [Related]
12. Cerebellar Mutism Syndrome After Posterior Fossa Tumor Surgery in Children-A Retrospective Single-Center Study.
Schmidt S; Kovacs E; Usta D; Behnisch R; Sahm F; Haux D; Witt O; Milde T; Unterberg A; El Damaty A
World Neurosurg; 2023 May; 173():e622-e628. PubMed ID: 36871657
[TBL] [Abstract][Full Text] [Related]
13. Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study.
Palmer SL; Armstrong C; Onar-Thomas A; Wu S; Wallace D; Bonner MJ; Schreiber J; Swain M; Chapieski L; Mabbott D; Knight S; Boyle R; Gajjar A
J Clin Oncol; 2013 Oct; 31(28):3494-500. PubMed ID: 23980078
[TBL] [Abstract][Full Text] [Related]
14. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
16. Clinical and neuroanatomical predictors of cerebellar mutism syndrome.
Law N; Greenberg M; Bouffet E; Taylor MD; Laughlin S; Strother D; Fryer C; McConnell D; Hukin J; Kaise C; Wang F; Mabbott DJ
Neuro Oncol; 2012 Oct; 14(10):1294-303. PubMed ID: 22952198
[TBL] [Abstract][Full Text] [Related]
17. A comparison study assessing neuropsychological outcome of patients with post-operative pediatric cerebellar mutism syndrome and matched controls after proton radiation therapy.
Grieco JA; Abrams AN; Evans CL; Yock TI; Pulsifer MB
Childs Nerv Syst; 2020 Feb; 36(2):305-313. PubMed ID: 31325031
[TBL] [Abstract][Full Text] [Related]
18. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin.
Wells EM; Khademian ZP; Walsh KS; Vezina G; Sposto R; Keating RF; Packer RJ
J Neurosurg Pediatr; 2010 Apr; 5(4):329-34. PubMed ID: 20367335
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
Malbari F; Gill J; Daigle A; Rodriguez LL; Raghubar KP; Davis KC; Scheurer M; Ma MM; Kralik SF; Meoded A; Okcu MF; Chintagumpala MM; Aldave G; Weiner HL; Kahalley LS
Pediatr Neurol; 2022 Jul; 132():4-10. PubMed ID: 35598587
[TBL] [Abstract][Full Text] [Related]
20. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
